Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia

NCT06262542 is registered in ClinicalTrials.gov with Taichung Armed Forces General Hospital as lead sponsor.

NCT NCT06262542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06262542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia
Lead sponsor
Taichung Armed Forces General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 13, 2024
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemotherapy-induced leukopenia, chinese herb medicine-moxibustion